OCD Clinical Trials in Philadelphia, PA

OCD Clinical Trials in Philadelphia, PA

View the best 10 obsessive compulsive disorder (ocd) medical studies in Philadelphia, Pennsylvania. Access promising new therapies by applying to a Philadelphia-based OCD clinical trial.

Trials in Philadelphia, Pennsylvania

Here are the top 4 medical studies for obsessive compulsive disorder (ocd) in Philadelphia, Pennsylvania

Image of University of Pennsylvania in Philadelphia, United States.

Exposure & Response Prevention (EX/RP)

Behavioral Intervention

Recruiting1 award7 criteria
This trial studies how hormonal changes during the menstrual cycle affect the effectiveness of a common OCD therapy called Exposure and Response Prevention (EX/RP). Women will undergo therapy at various points in their cycle, and men will also participate for comparison. The goal is to see if timing therapy with hormonal changes can improve outcomes for women with OCD.
Image of Weill Cornell Medicine in New York, United States.

Accelerated TMS

Behavioural Intervention

Recruiting1 award4 criteria
This trial tests a new, faster treatment for people with depression and OCD. The goal is to see if this approach can quickly improve symptoms. The study also uses brain scans to find markers that predict who will benefit most from the treatment. This method has shown effectiveness in treating depression and cognitive impairment, and is being explored for its potential in treating OCD.
Image of UT Health Science Center at Houston in Houston, United States.

Reclaim™ DBS Therapy

Procedure

Recruiting1 award8 criteria
This trial involves using Deep Brain Stimulation (DBS) to help patients with severe OCD who haven't responded to other treatments. The DBS device sends electrical signals to specific brain areas to control OCD symptoms by regulating abnormal brain activity.
Image of Metropolitan Neuro Behavioral Institute in Chandler, United States.

Troriluzole (BHV-4157)

Recruiting2 awardsPhase 3
This trial is testing the safety and tolerability of troriluzole as an additional treatment for people with OCD. Troriluzole may help balance brain chemicals to reduce OCD symptoms. Troriluzole is related to riluzole, which has been studied for its potential benefits in treating anxiety disorders and OCD.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.